Journal articlePreclinical

[The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain]

Molekuliarnaia biologiia, 2021 May-Jun. Dergunova LV, Dmitrieva VG, Filippenkov IB and 9 others.

Study type

Journal article

Subjects

Animal / preclinical (no Humans MeSH term)

Journal

Molekuliarnaia biologiia

Published

2021 May-Jun

PubMed

PMID 34097675 ↗

DOI

10.31857/S0026898421010043 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

N-Acetyl Semax Amidate →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Adrenocorticotropic HormoneAnimalsBrainBrain IschemiaIschemiaNeuroprotective AgentsPeptide FragmentsPharmaceutical PreparationsRNA, MessengerRatsRats, Wistar

Other papers on N-Acetyl Semax Amidate

Clinical trial · 2018

[The efficacy of semax in the tretament of patients at different stages of ischemic stroke]

Journal article · 2011

[The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete global ischemia]

Journal article · 2006

Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page